Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.700.640.790.981.08

What is the latest Fixed Capital/Sales ratio of BAFNA PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of BAFNA PHARMACEUTICALS is 0.70 based on Mar2025 Standalone results.
Year Fixed Capital/Sales
Mar20250.70
Mar20240.64
Mar20230.79
Mar20220.98
Mar20211.08

How is Fixed Capital/Sales of BAFNA PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.7
9.37
Mar2024 0.64
-18.99
Mar2023 0.79
-19.39
Mar2022 0.98
-9.26
Mar2021 1.08 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹251.9 Cr -8.1% -8.5% 35.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,185.0 Cr 3% 9.5% 3.1% Stock Analytics
DIVIS LABORATORIES ₹171,766.0 Cr 1.7% 3.1% 5.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,923.0 Cr 4.7% 11.7% 41.1% Stock Analytics
DR REDDYS LABORATORIES ₹110,081.0 Cr 2.1% 6.7% 11.6% Stock Analytics
CIPLA ₹109,680.0 Cr 1.3% 1.3% -9.4% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-8.1%

-8.5%

35.6%

SENSEX

-0.3%

-0.1%

8.3%


You may also like the below Video Courses